Alexander Kutikov, MD
Dr. Kutikov is a Professor and Chair of Urology and Urologic Oncology and Roberta R. Scheller Endowed Chair in Urologic Oncology at the Fox Chase Cancer Center. He is a board certified, academic urologic surgical oncologist who treats urologic tumors using minimally invasive (robotic / laparoscopic) and traditional surgical techniques. Dr. Kutikov graduated Summa Cum Laude from Emory University with a B.S. in Chemistry where he attended on a full merit-based scholarship. During the junior year, he was selected as the sole student to represent Emory at Oxford University, England. Following undergraduate studies, Alexander received an MD from Harvard Medical School’s Harvard-MIT Health Sciences and Technology Program in 2003. Dr. Kutikov completed Urologic residency training at the University of Pennsylvania in 2008 and finished a 2-year Society of Urologic Oncology fellowship at the Fox Chase Cancer Center in Philadelphia, USA. Alexander has co-authored more than 230 original manuscripts in peer-reviewed journals. He has published chapters in leading urologic textbooks, including the definitive chapter on adrenal disorders in “Campbell-Walsh Urology,” and has held leadership positions both in the American College of Surgeons and the American Urological Association. https://www.foxchase.org/alexander-kutikov
Financial relationships
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Oncosec ImmunotherapiesDate added:Date updated:11/04/2023
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Merck, IncDate added:Date updated:11/04/2023
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:UrologyMatch.com LLCDate added:Date updated:11/04/2023
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Oncosec ImmunotherapiesDate added:Date updated:11/04/2023
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Merck, IncDate added:Date updated:11/04/2023
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:UrologyMatch.com LLCDate added:Date updated:11/04/2023
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Oncosec ImmunotherapiesDate added:Date updated:11/04/2023
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Merck, IncDate added:Date updated:11/04/2023
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:UrologyMatch.com LLCDate added:Date updated:11/04/2023
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Oncosec ImmunotherapiesDate added:Date updated:11/04/2023